Skip to Content
MilliporeSigma
  • A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.

A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.

Biochimica et biophysica acta (2002-10-19)
Jürgen G Okun, Stefan Kölker, Andreas Schulze, Dirk Kohlmüller, Katharina Olgemöller, Martin Lindner, Georg F Hoffmann, Ronald J A Wanders, Ertan Mayatepek
ABSTRACT

Inherited disorders of fatty acid oxidation are a group of acute life-threatening but treatable disorders, clinically complicated by severe hypoketotic hypoglycemia precipitated by prolonged fasting. Among them, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is by far the most frequent disorder. Here we report a modified method for quantitative acylcarnitine profiling by electrospray ionisation-tandem mass spectrometry (ESI-MS-MS) in human skin fibroblasts using unlabelled palmitic acid as substrate. The reliability of this method was tested in cultured skin fibroblasts from previously diagnosed patients with specific carnitine cycle and fatty acid beta-oxidation defects. Furthermore, acylcarnitine profiling was investigated in fibroblasts and dried blood spots from patients with different variants of MCAD deficiency. ESI-MS-MS-based investigation of cultured skin fibroblasts from patients with disorders of fatty acid oxidation revealed a pathognomonic acylcarnitine profiling. In addition, this method delineated different variants of MCAD deficiency, i.e. mild and classical. The octanoylcarnitine (C8)-to-decanoylcarnitine (C10) and C8-to-acetylcarnitine (C2) ratios were the most specific markers to differentiate mild and classical forms of MCAD deficiency in fibroblasts. Similar results were obtained by quantitative acylcarnitine profiling in dried blood spots. In conclusion, this novel technique is a powerful tool for the investigation of fatty acid oxidation disorders under standardized conditions in fibroblasts.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Palmitic acid, ≥98%, FCC, FG
SKU
Pack Size
Availability
Price
Quantity
Supelco
Palmitic acid, analytical standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Palmitic acid, ≥99%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
SKU
Pack Size
Availability
Price
Quantity
Palmitic acid, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Palmitic acid, natural, 98%, FG
SKU
Pack Size
Availability
Price
Quantity
Supelco
Palmitic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
SKU
Pack Size
Availability
Price
Quantity
Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Decanoyl-L-carnitine, ≥94.0% (HPLC)
SKU
Pack Size
Availability
Price
Quantity